Most patients will not see significant HbA1c reduction until they have been on a therapeutic dose (0.5 mg or higher) for at least 812 weeks
The latter has been used for the long term management of obesity since its FDA approval several years ago
Novo Nordisk is awaiting an FDA decision for their fixed-dose combination of the amylin receptor agonist, cagrilintide, and the GLP-1, semaglutide
TMAO has been implicated in the development and progression of chronic inflammatory diseases, including atherosclerosis, chronic kidney disease, obesity, non-alcoholic fatty liver disease (NAFLD), Alzheimers disease and cancer [2, 1216]
In this study of FM/chronic fatigue syndrome, patients who were good responders were found to be using a higher and more frequent doses of vitamin B12 for a longer period [17]
Pre-surgical stabilisation with antithyroid medication or an iodine-restricted food is recommended